Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Accumulated Expenses: 2022-2025

Historic Accumulated Expenses for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to $984,547.

  • bioAffinity Technologies' Accumulated Expenses rose 8.88% to $984,547 in Q3 2025 from the same period last year, while for Sep 2025 it was $984,547, marking a year-over-year increase of 8.88%. This contributed to the annual value of $1.4 million for FY2024, which is 21.65% up from last year.
  • Latest data reveals that bioAffinity Technologies reported Accumulated Expenses of $984,547 as of Q3 2025, which was down 6.06% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Accumulated Expenses ranged from a high of $1.6 million in Q3 2022 and a low of $481,336 during Q1 2023.
  • Over the past 3 years, bioAffinity Technologies' median Accumulated Expenses value was $969,093 (recorded in 2024), while the average stood at $940,845.
  • Within the past 5 years, the most significant YoY rise in bioAffinity Technologies' Accumulated Expenses was 112.18% (2023), while the steepest drop was 59.76% (2023).
  • bioAffinity Technologies' Accumulated Expenses (Quarterly) stood at $541,894 in 2022, then skyrocketed by 112.18% to $1.1 million in 2023, then grew by 21.65% to $1.4 million in 2024, then climbed by 8.88% to $984,547 in 2025.
  • Its Accumulated Expenses was $984,547 in Q3 2025, compared to $1.0 million in Q2 2025 and $1.4 million in Q1 2025.